CAS 2005486-31-5

Ebopiprant

CAS : 2005486-31-5

Ebopiprant

Degré de pureté : ≥98%

Masse moléculaire : 599.74g/mol

Ref: 54-BUP21831

(S)-2-Amino-3-methyl-butyric acid (S)-3-(((S)-3-(biphenyl-4-sulfonyl)-thiazolidine-2-carbonyl)-amino)-3-(4-fluoro-phenyl)-propyl est er

CAS : 2005486-31-5

(S)-2-Amino-3-methyl-butyric acid (S)-3-(((S)-3-(biphenyl-4-sulfonyl)-thiazolidine-2-carbonyl)-amino)-3-(4-fluoro-phenyl)-propyl ester is an orally administered prodrug that is metabolized to betamethasone. It has been used in clinical studies for the prevention of preterm birth in women with pregnancies at risk for preterm delivery. This drug is also used for the treatment of inflammation and pain. The dose groups were determined based on a concentration–time curve and there have been no reports of cardiac side effects or drug interactions.

Formule : C₃₀H₃₄FN₃O₅S₂

Degré de pureté : Min. 95%

Masse moléculaire : 599.7 g/mol

Ref: 3D-FFD48631

Ebopiprant

CAS : 2005486-31-5

Ebopiprant (OBE022) is a prostaglandin F2α (PGF2α) receptor antagonist that can be used to study obesity.

Formule : C₃₀H₃₄FN₃O₅S₂

Degré de pureté : 98.73%

Couleur et forme : Solid

Masse moléculaire : 599.74

Ref: TM-T12285